Canada markets close in 4 hours 25 minutes

Invitae Corporation (NVTA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.6801+0.0101 (+1.51%)
As of 11:35AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.6700
Bid0.6680 x 3100
Ask0.6695 x 900
Day's Range0.6324 - 0.6801
52 Week Range0.6324 - 3.7750
Avg. Volume9,844,434
Market Cap183.934M
Beta (5Y Monthly)1.70
PE Ratio (TTM)N/A
EPS (TTM)-2.7200
Earnings DateNov 06, 2023 - Nov 10, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.84

    Invitae aims to regain NYSE compliance after average share price falls below $1

    San Francisco-based medical genetics company, Invitae (NYSE:NVTA), received a notice from the New York Stock Exchange (NYSE) on Tuesday, indicating that the firm is not in compliance with Section 802.01C of the NYSE Listed Company Manual. The violation was due to the average closing price of Invitae's common stock falling below $1.00 per share over a consecutive 30 trading-day period.

  • Motley Fool

    Invitae Stock Analysis: Buy, Sell, or Hold? contributor Parkev Tatevosian considers Invitae (NYSE: NVTA) stock and its financial prospects to determine if investors should buy the stock. *Stock prices used were the afternoon prices of Sept.


    Novavax and Invitae implement cost-cutting measures amid financial challenges

    In the volatile world of stock trading, healthcare companies Novavax (NASDAQ:NVAX) and Invitae (NYSE:NVTA) have been making headlines as they navigate significant financial challenges. Both firms are taking measures to reduce costs, aiming to improve their financial standing and appeal to a broader range of investors.